Laboratory for Neurobiology and Gene Therapy, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium.
Gene Ther. 2011 Jun;18(6):594-605. doi: 10.1038/gt.2011.2. Epub 2011 Feb 24.
The development of in vivo imaging protocols to reliably track transplanted cells or to report on gene expression is critical for treatment monitoring in (pre)clinical cell and gene therapy protocols. Therefore, we evaluated the potential of lentiviral vectors (LVs) and adeno-associated viral vectors (AAVs) to express the magnetic resonance imaging (MRI) reporter gene ferritin in the rodent brain. First, we compared the induction of background MRI contrast for both vector systems in immune-deficient and immune-competent mice. LV injection resulted in hypointense (that is, dark) changes of T(2)/T(2)() (spin-spin relaxation time)-weighted MRI contrast at the injection site, which can be partially explained by an inflammatory response against the vector injection. In contrast to LVs, AAV injection resulted in reduced background contrast. Moreover, AAV-mediated ferritin overexpression resulted in significantly enhanced contrast to background on T(2)()-weighted MRI. Although sensitivity associated with the ferritin reporter remains modest, AAVs seem to be the most promising vector system for in vivo MRI reporter gene imaging.
为了对(临床前)细胞和基因治疗方案进行治疗监测,开发可靠地追踪移植细胞或报告基因表达的体内成像方案对于治疗监测至关重要。因此,我们评估了慢病毒载体(LVs)和腺相关病毒载体(AAVs)在啮齿动物大脑中表达磁共振成像(MRI)报告基因铁蛋白的潜力。首先,我们比较了两种载体系统在免疫缺陷和免疫功能正常小鼠中诱导背景 MRI 对比的情况。LV 注射导致注射部位 T2/T2*(自旋-自旋弛豫时间)加权 MRI 对比出现低信号(即暗)变化,这部分可以通过针对载体注射的炎症反应来解释。与 LVs 相反,AAV 注射导致背景对比减少。此外,AAV 介导的铁蛋白过表达导致 T2*加权 MRI 上的对比明显增强。尽管与铁蛋白报告基因相关的敏感性仍然较低,但 AAV 似乎是体内 MRI 报告基因成像最有前途的载体系统。